ABILITY Neurotech receives MREC approval for ALS BCI clinical trial

​ABILITY Neurotech has secured approval from the MREC NedMec in the Netherlands to initiate a chronic clinical trial of its fully implantable wireless BCI in patients with ALS.

The post ABILITY Neurotech receives MREC approval for ALS BCI clinical trial appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.